SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Qian Gao; Xia Ye; Fei Li
  • Source:
    Alternative Therapies in Health & Medicine. Sep2024, Vol. 30 Issue 9, p286-293. 8p.
  • Additional Information
    • Subject Terms:
      RENAL cell carcinoma; CANCER prognosis; GENE expression; CANCER treatment; PROTEIN-protein interactions; NEPHRONS
    • Abstract:
      Objective • Clear renal cell carcinoma (ccRCC) is a common and deadly urinary system tumor. The TNM system determines treatment and prognosis based on cancer advancement. While nephron-sparing surgery is an option for localized ccRCC, advanced cases are challenging, and molecular-targeted therapy is crucial. Methods • Here, we implemented microarray datasets to identify a total of 119 differentially expressed genes (DEGs) and ten hub genes by a protein-protein interaction network (PPI) and performed module analysis through STRING and Cytoscape. Results • Data from this analysis shed light on a positive correlation between SLC12A3 (solute carrier family 12 member 3) and tumor-correlated cells. SLC12A3 can predict prognosis and immune infiltration levels in KIRC patients. Conclusion • Our findings demonstrated that SLC12A3 expression accounts for favorable prognosis and increased immune infiltration of various cell types. This could lead to potential therapeutic aims and biomarkers for KIRC (kidney renal clear cell carcinoma). [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Alternative Therapies in Health & Medicine is the property of InnoVisions Professional Media and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)